Literature DB >> 12686348

Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.

Heather M Abourjaily1, Alawi A Alsheikh-Ali, Richard H Karas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12686348     DOI： 10.1016/s0002-9149(03)00124-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

1.  Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.

Authors:  Ine B Skottheim; Martin P Bogsrud; Monica Hermann; Kjetil Retterstøl; Anders Åsberg
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

2.  Atorvastatin-induced prolonged cholestasis with bile duct damage.

Authors:  Manuela Merli; Maria Consiglia Bragazzi; Federica Giubilo; Francesco Callea; Adolfo F Attili; Domenico Alvaro
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution.

Authors:  Ryohei Miyata; Ni Bai; Renaud Vincent; Don D Sin; Stephan F Van Eeden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.